Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02013492 | Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery | completed | Early Phase 1 | 1 | William CarsonOTHER | 1 | Dec 6, 2022 | clinicaltrials |
| NCT05638828 | A Study of RD14-01 in Patients With Advanced Solid Tumors | unknown | Early Phase 1 | 24 | Shen LinOTHER | 0 | Dec 6, 2022 | clinicaltrials |
| NCT05623891 |
| Safety Study of 177Lu-Anti-ED-B mAbs SPECT Imaging in Patients With ED-B Positive Solid Tumors |
| unknown |
| Early Phase 1 |
| 10 |
| Affiliated Hospital of Jiangnan UniversityOTHER |
| 1 |
| Nov 23, 2022 |
| clinicaltrials |
| NCT05271279 | A Study of OVV-01 Injection in Combination With IBR900 Cell Injection in Patients With Advanced Malignant Tumors | terminated | Early Phase 1 | 2 | Beijing Boren HospitalOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT05373147 | αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors | unknown | Early Phase 1 | 21 | Shanghai Mengchao Cancer HospitalOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT05539768 | Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Solid Tumor | not yet recruiting | Early Phase 1 | 8 | The Affiliated Hospital of Qingdao UniversityOTHER | 0 | Sep 14, 2022 | clinicaltrials |
| NCT05515185 | B7-H3 Targeting CAR-T Cells Therapy for B7-H3 Positive Solid Tumors | unknown | Early Phase 1 | 30 | The First People's Hospital of LianyungangOTHER | 1 | Aug 25, 2022 | clinicaltrials |
| NCT04891718 | CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia | withdrawn | Early Phase 1 | 0 | Presage BiosciencesINDUSTRY | 1 | Jul 8, 2022 | clinicaltrials |
| NCT05382377 | NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors | unknown | Early Phase 1 | 18 | jianming xuOTHER | 1 | May 19, 2022 | clinicaltrials |
| NCT04803630 | Thermal Therapy for the Treatment of Depression in Cancer Survivors, the S-WARM Study | withdrawn | Early Phase 1 | 0 | Roswell Park Cancer InstituteOTHER | 1 | May 12, 2022 | clinicaltrials |
| NCT05287165 | Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms | unknown | Early Phase 1 | 19 | Beijing Immunochina Medical Science & Technology Co., Ltd.INDUSTRY | 1 | Mar 18, 2022 | clinicaltrials |
| NCT05284968 | RD07 Cell Injection in the Treatment of Patients With Advanced Claudin18.2 Positive Solid Tumors | unknown | Early Phase 1 | 36 | Peking UniversityOTHER | 0 | Mar 17, 2022 | clinicaltrials |
| NCT05275062 | Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma | unknown | Early Phase 1 | 6 | Beijing Immunochina Medical Science & Technology Co., Ltd.INDUSTRY | 1 | Mar 11, 2022 | clinicaltrials |
| NCT05194709 | Study of Anti-5T4 CAR-NK Cell Therapy in Advanced Solid Tumors | unknown | Early Phase 1 | 40 | Wuxi People's HospitalOTHER | 1 | Feb 2, 2022 | clinicaltrials |
| NCT05166070 | An Exploratory Clinical Study of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors | recruiting | Early Phase 1 | 24 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Dec 21, 2021 | clinicaltrials |
| NCT00424242 | Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases | completed | Early Phase 1 | 15 | Northwestern UniversityOTHER | 1 | Sep 8, 2021 | clinicaltrials |
| NCT04841421 | Clinical Study on PET Imaging, Distribution and PK of 89Zr-CD147 in Patients With Solid Tumors | unknown | Early Phase 1 | 30 | Sinotau Pharmaceutical GroupINDUSTRY | 0 | Apr 12, 2021 | clinicaltrials |
| NCT04076137 | Targeted T-cell Therapy in Solid Tumors | unknown | Early Phase 1 | 10 | Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.INDUSTRY | 1 | Sep 3, 2019 | clinicaltrials |
| NCT04046016 | A Study Using Whole-body PET After Oral Microdose of 18F-labeled Liporaxel in Patients With Solid Tumor | completed | Early Phase 1 | 2 | Seoul National University HospitalOTHER | 1 | Aug 6, 2019 | clinicaltrials |
| NCT02646319 | Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations | completed | Early Phase 1 | 2 | Mayo ClinicOTHER | 1 | Jun 6, 2019 | clinicaltrials |
| NCT02285738 | Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis | completed | Early Phase 1 | 17 | Case Comprehensive Cancer CenterOTHER | 1 | May 8, 2019 | clinicaltrials |
| NCT03815084 | A Study of PD1 Combined With DC-NK Cell in the Treatment of Solid Tumors | unknown | Early Phase 1 | 100 | Allife Medical Science and Technology Co., Ltd.INDUSTRY | 0 | Jan 30, 2019 | clinicaltrials |
| NCT03815630 | A Study of PD1 Combined With Dc-cik in the Treatment of Solid Tumors(DC-CIK) | unknown | Early Phase 1 | 100 | Allife Medical Science and Technology Co., Ltd.INDUSTRY | 0 | Jan 30, 2019 | clinicaltrials |
| NCT00896792 | Nurse Practitioner Hospice Program for Patients With Terminal Metastatic Cancer and Their Families or Caregivers | completed | Early Phase 1 | 26 | Mayo ClinicOTHER | 1 | Oct 9, 2018 | clinicaltrials |
| NCT02157831 | Redosing With CP-870, 893 in Patients With Clinical Benefit After a Single Infusion From A Phase I, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors | completed | Early Phase 1 | 10 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Aug 17, 2018 | clinicaltrials |
| NCT02653196 | A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors | terminated | Early Phase 1 | 1 | Montefiore Medical CenterOTHER | 1 | Aug 17, 2017 | clinicaltrials |
| NCT01632696 | Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors | terminated | Early Phase 1 | 11 | Peregrine PharmaceuticalsINDUSTRY | 1 | Jul 11, 2017 | clinicaltrials |
| NCT02735798 | 64-Cu Labeled Brain PET/MRI for MM-302 in Advanced HER2+ Cancers With Brain Mets | withdrawn | Early Phase 1 | 0 | Pamela MunsterOTHER | 0 | May 4, 2017 | clinicaltrials |
| NCT00816335 | Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors | completed | Early Phase 1 | 65 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 4, 2016 | clinicaltrials |
| NCT02446431 | Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence(Metronomic) | recruiting | Early Phase 1 | 20 | Miller Children's & Women's Hospital Long BeachOTHER | 1 | May 18, 2015 | clinicaltrials |
| NCT00583063 | Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers | completed | Early Phase 1 | 23 | University of ChicagoOTHER | 1 | Jun 12, 2013 | clinicaltrials |
| NCT00253461 | 11C Topotecan PET Imaging | terminated | Early Phase 1 | 7 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Dec 6, 2022source: clinicaltrials